How CAR T-Cell Therapy Impacts Relapsed/Refractory MM Treatment
Yi Lin, MD, PhD, provides insights on the impact of CAR T-cell therapy on the evolving multiple myeloma treatment landscape.
Video content above is prompted by the following questions:
- What is the impact of CAR T-cell therapy on patient quality of life and how does it compare to other available treatments?
- How do patients typically respond to CAR T-cell therapy in terms of their overall well-being and ability to perform daily activities?
- Are there any long-term quality of life benefits or challenges associated with CAR T-cell therapy?
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Recent Videos
Related Content
